Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: AYUSH 64: AYUSH 64 02 Capsules of 500mg each orally thrice daily for 14 days as add-on therapy to supportive and symptomatic allopathic treatment for COVID 19 patients
Control Intervent
Sponsors
IPGT and RA
Eligibility
Inclusion criteria
Inclusion criteria: Asymptomatic or minimal symptomatic COVID 19 patients Patients having 0 to 4 score as per the WHO ordinal scale for clinical improvement Age 18 to 70years Patients who can take oral medicine Patients who are ready to give written consent
Exclusion criteria
Exclusion criteria: Age below 18 and above 70years Patients having severe symptoms of COVID19 Patients on mechanical ventilator or organ support Patients do not able to take oral medication Pregnant and lactating women Oncological diseases and other systemic uncontrol conditions such as HTN diabetes etc Liver or kidney malfunctions. Severe pneumonia Acute respiratory distress syndrome Sepsis and Septic Shock
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ordinal scale for Clinical improvement as per WHO Duration on mechanical ventilator All cause mortality Timepoint: 0 7 14 and 28th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of patients developed symptomsTimepoint: 0 14 and 28th day;Number of patients who needed oxygen therapyTimepoint: 0 14 and 28th day;Number of patients who needed mechanical ventilatorTimepoint: 0 14 and 28th day;Total duration of symptomatic phaseTimepoint: 0 14 and 28th day;Duration on oxygen therapyTimepoint: 0 7 14 and 28th day;Number of cases reporting any ADR AE Timepoint: 0 7 14 and 28th day | — |
Countries
India
Contacts
Public ContactDr Sagar M Bhinde
IPGTRA Jamnagar
Outcome results
None listed